- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
How to Identify & Evaluate Chronic Kidney Disease Using eGFR and UACR: In brief
The primary care professional is essential to early detection and ongoing management of chronic kidney disease and primary interventions can help delay the need for referral to a nephrologist.
There are several professional society guidelines available to guide care, although the recommendations may conflict at times, according to the National Kidney Disease Education Program (NKDEP).
The NKDEP created a concise guide specifically for the busy primary care professional that highlights the most important considerations for diagnosing and slowing the progression of CKD. The slides that follow offer a look at the 2 key laboratory studies used to detect CKD as presented by the NKDEP, and in brief.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14th 2024Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
